# EDGAR Filing Document

**Accession Number:** 0001965703
**File Stem:** 0001193125-25-278189
**Filing Date:** 2025-11
**Character Count:** 8027
**Document Hash:** 8c4cd42de09f0c4f4dc9f0810fb77a15
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-278189.hdr.sgml**: 20251112

**ACCESSION NUMBER**: 0001193125-25-278189

**CONFORMED SUBMISSION TYPE**: 4/A

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250306

**FILED AS OF DATE**: 20251112

**DATE AS OF CHANGE**: 20251112

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Varanakis Ann
- **CENTRAL INDEX KEY:** 0001965703

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40478
- **FILM NUMBER:** 251474750

**MAIL ADDRESS:**
- **STREET 1:** 4800 N. SCOTTSDALE ROAD
- **STREET 2:** SUITE 6000
- **CITY:** SCOTTSDALE
- **STATE:** AZ
- **ZIP:** 85251
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LifeStance Health Group, Inc.
- **CENTRAL INDEX KEY:** 0001845257
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HEALTH SERVICES [8000]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 4800 N. SCOTTSDALE ROAD
- **STREET 2:** SUITE 2500
- **CITY:** SCOTTSDALE
- **STATE:** AZ
- **ZIP:** 85251
- **BUSINESS PHONE:** 602-767-2100

**MAIL ADDRESS:**
- **STREET 1:** 4800 N. SCOTTSDALE ROAD
- **STREET 2:** SUITE 2500
- **CITY:** SCOTTSDALE
- **STATE:** AZ
- **ZIP:** 85251

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4/A

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Varanakis Ann<br><sub>(Last) (First) (Middle)</sub><br>C/O LIFESTANCE HEALTH GROUP, INC.<br>4800 N. SCOTTSDALE ROAD, SUITE 2500<br><sub>(Street)</sub><br>SCOTTSDALE, AZ 85251<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-03-06 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief People Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>LifeStance Health Group, Inc. [ LFST ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-03-06 |  | A |  | 76142<sup>(1)</sup> | A | $0.00 | 339149 | D |  |
| Common Stock | 2025-03-06 |  | F<sup>(2)</sup> |  | 6455 | D | $7.88 | 332694 | D |  |
| Common Stock | 2025-03-07 |  | A |  | 27740<sup>(3)</sup> | A | $0.00 | 360434 | D |  |
| Common Stock | 2025-03-07 |  | F<sup>(4)</sup> |  | 7450 | D | $7.59 | 352984 | D |  |
| Common Stock | 2025-03-07 |  | A |  | 32052<sup>(5)</sup> | A | $0.00 | 385036 | D |  |
| Common Stock | 2025-03-07 |  | F<sup>(6)</sup> |  | 8606 | D | $7.59 | 376430 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Includes 76,142 restricted stock units ("RSUs") granted on March 6, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

(2) Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

(3) Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 8, 2024, which vested on March 7, 2025.

(4) Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.

(5) Represents PSUs previously granted to the Reporting Person on February 28, 2024, which vested on March 7, 2025.

(6) Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.

**Remarks:**
The Form 4 previously filed on March 10, 2025 reported that 3,725 shares were withheld by the Issuer to satisfy withholding tax obligations in connection with the net settlement of PSUs that vested on March 7, 2025 as 3,725 in the fourth row of table 1 above. This Form 4 is being filed to amend the number of shares withheld to be 7,450 and to update the number of shares reported as securities beneficially owned following the reported transaction.

**Signature:** By: /s/ Ryan Pardo, Attorney-in-Fact  
**Date:** 2025-11-12

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**